Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Change in Inventory: 2010-2025

Historic Change in Inventory for Anika Therapeutics (ANIK) over the last 13 years, with Sep 2025 value amounting to $443,000.

  • Anika Therapeutics' Change in Inventory fell 85.25% to $443,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.2 million, marking a year-over-year decrease of 128.09%. This contributed to the annual value of $9.4 million for FY2024, which is 17.30% down from last year.
  • Latest data reveals that Anika Therapeutics reported Change in Inventory of $443,000 as of Q3 2025, which was up 125.62% from -$1.7 million recorded in Q2 2025.
  • Anika Therapeutics' Change in Inventory's 5-year high stood at $4.7 million during Q2 2024, with a 5-year trough of -$2.4 million in Q4 2024.
  • Over the past 3 years, Anika Therapeutics' median Change in Inventory value was $3.0 million (recorded in 2024), while the average stood at $1.7 million.
  • In the last 5 years, Anika Therapeutics' Change in Inventory surged by 690.36% in 2022 and then tumbled by 176.17% in 2024.
  • Over the past 5 years, Anika Therapeutics' Change in Inventory (Quarterly) stood at -$498,000 in 2021, then skyrocketed by 690.36% to $2.9 million in 2022, then increased by 6.77% to $3.1 million in 2023, then tumbled by 176.17% to -$2.4 million in 2024, then plummeted by 85.25% to $443,000 in 2025.
  • Its last three reported values are $443,000 in Q3 2025, -$1.7 million for Q2 2025, and -$523,000 during Q1 2025.